Broadfin Capital’s ContraFect Corporation CFRX Stock Holding History

Broadfin Capital’s Portfolio CFRX Stock Details CFRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-487	Closed	-$633K	–	68
2018 Q1	$633K	Sell	487 -1,053	-68%	-$1.3M	0.1%	49
2017 Q4	$1.24M	Sell	1,540 -1,849	-55%	-$1.53M	0.2%	39
2017 Q3	$3.01M	Buy	3,389 +1,732	+105%	+$1.64M	0.45%	40
2017 Q2	$1.92M	Sell	1,657 -129	-7%	-$151K	0.23%	48
2017 Q1	$2.57M	Hold	1,786	–	–	0.31%	45
2016 Q4	$2.5M	Hold	1,786	–	–	0.28%	57
2016 Q3	$3.54M	Buy	1,786 +970	+119%	+$1.9M	0.32%	61
2016 Q2	$1.89M	Sell	816 -240	-23%	-$609K	0.18%	60
2016 Q1	$2.87M	Sell	1,056 -717	-40%	-$2.03M	0.28%	61
2015 Q4	$6.74M	Hold	1,773	–	–	0.41%	59
2015 Q3	$6.31M	Hold	1,773	–	–	0.35%	62
2015 Q2	$5.96M	Buy	+1,773	New	+$7.19M	0.32%	69

Other funds holding CFRX

Fosun International Hong Kong, China $399M AUM 16.11% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

OIM

Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return

Broadfin Capital's CFRX Position: Q2 2018 in Review

Broadfin Capital sold out of ContraFect Corporation (CFRX) in Q2 2018, closing a stake of 487 shares — an estimated $633K sold.

Broadfin Capital first reported a position in CFRX in Q2 2015 and held it in 12 quarters. The position peaked at $6.74M in Q4 2015. 38 funds tracked by Wall St. Rank hold CFRX as of Q2 2018.

Broadfin Capital reported no remaining ContraFect Corporation position as of Q2 2018 after selling out during the quarter.
Broadfin Capital sold 487 ContraFect Corporation shares in Q2 2018, an estimated $633K.
Broadfin Capital first reported a position in ContraFect Corporation in Q2 2015 and held it in 12 quarters.
Broadfin Capital's ContraFect Corporation position peaked at $6.74M in Q4 2015.
38 funds tracked by Wall St. Rank held ContraFect Corporation as of Q2 2018.

Based on Broadfin Capital's 13F filing for Q2 2018, filed 14 Aug 2018.